Search Within

Joachim Yahalom

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Meeting Abstract (49)
  2. Journal Article (22)
  3. Research Letter (2)
  4. Review (1)
Groups
  1. Radiation Oncology, Department of (74)
  2. Sloan Kettering Institute Postdocs (74)
  3. Survivorship Research (74)
  4. Department of Medicine (60)
  5. Hematologic Malignancies, Division of (59)
  6. Graduate Medical Education (49)

More Groups

People
  1. Brandon Imber (42)
  2. Maria Palomba (34)
  3. Erel Joffe (31)
  4. Gilles Salles (30)
  5. Carla Hajj (28)
  6. Alison Moskowitz (26)

More People

Years
  1. 2025 (2)
  2. 2024 (8)
  3. 2023 (23)
  4. 2022 (8)
  5. 2021 (9)
  6. 2020 (8)

More Years

Publications
  1. Blood (19)
  2. Hematological Oncology (15)
  3. International Journal of Radiation Oncology, Biology, Physics (11)
  4. Blood Advances (5)
  5. Radiotherapy and Oncology (4)
  6. Journal of Clinical Oncology (3)

More Publications

Publishers
  1. American Society of Hematology (24)
  2. Elsevier Inc. (17)
  3. Wiley Blackwell (16)
  4. Nature Publishing Group (4)
  5. American Society of Clinical Oncology (3)
  6. Taylor & Francis Group (3)

More Publishers

Results (74)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma
    Journal Article

    Sha, F.; Okwali, M.; Alperovich, A.; Caron, P. C.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; Khan, N.; more...
    Blood Cancer Journal (2022)

    Fulltext@MSK | Save
  • Novel agents may be preferable to chemotherapy for large B-cell lymphoma progressing after CD19-CAR-T: A multicenter observational study
    Meeting Abstract

    Tomas, A. A.; Fein, J. A.; Fried, S.; Fingrut, W.; Anagnostou, T.; Alperovich, A.; Shah, N.; Fraint, E.; Lin, R. J.; Scordo, M.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Favorable outcomes of patients with limited-stage ocular adnexal DLBCL treated in the rituximab era: Long-term follow-up of a single center experience
    Meeting Abstract

    Qualls, D.; Batlevi, C. L.; Caron, P. C.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; Khan, N.; Kumar, A.; Matasar, M. J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Clinical outcomes and CNS relapse risk in patients with primary cutaneous DLBCL, leg type treated in the rituximab era: Long-term follow-up of a single-center experience
    Meeting Abstract

    Falchi, L.; Qiu, A.; Ewalt, M. D.; Batlevi, C. L.; Caron, P. C.; Hamlin, P. A.; Hamilton, A.; Horwitz, S. M.; Joffe, E.; Khan, N.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Predictors of response to very low dose radiotherapy (4Gy) for indolent B-cell lymphomas: Is 4Gy also suitable for potentially curable patients?
    Meeting Abstract

    Imber, B. S.; Chau, K. W.; Lee, J.; Lee, J.; Chelius, M.; Hajj, C.; Wijetunga, N. A.; Yang, J. C.; Casey, D. L.; Shepherd, A. F.; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • Phase II trial of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Shah, G.; Schöder, H.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Ryu, S.; Sohail, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Excellent response to very-low-dose radiation (4 Gy) for indolent B-cell lymphomas: Is 4 Gy suitable for curable patients?
    Journal Article

    Imber, B. S.; Chau, K. W.; Lee, J.; Lee, J.; Casey, D. L.; Yang, J. C.; Wijentunga, N. A.; Shepherd, A.; Hajj, C.; Qi, S.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Clinical outcomes and the role of observation in early‐stage follicular lymphoma
    Meeting Abstract

    Sha, F.; Okwali, M.; Alperovich, A.; Caron, P. C.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; Kumar, A.; more...
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • Pathogenic ATM mutations in cancer and a genetic basis for radiotherapeutic efficacy
    Journal Article

    Pitter, K. L.; Casey, D. L.; Lu, Y. C.; Hannum, M.; Zhang, Z.; Song, X.; Pecorari, I.; McMillan, B.; Ma, J.; Samstein, R. M.; more...
    JNCI: Journal of the National Cancer Institute (2021)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of extranodal stage I diffuse large B-cell lymphoma in the rituximab era
    Journal Article

    Bobillo, S.; Joffe, E.; Lavery, J. A.; Sermer, D.; Ghione, P.; Noy, A.; Caron, P. C.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; more...
    Blood (2021)

    Fulltext@MSK | Save